National Health Investors, Inc. (NHI) Upgraded by Zacks Investment Research to Buy
Zacks Investment Research upgraded shares of National Health Investors, Inc. (NYSE:NHI) from a hold rating to a buy rating in a report issued on Friday morning. The brokerage currently has $86.00 price target on the real estate investment trust’s stock.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
A number of other analysts also recently commented on the stock. Capital One Financial Corporation assumed coverage on shares of National Health Investors in a report on Monday, October 23rd. They issued an equal weight rating on the stock. BMO Capital Markets reiterated a hold rating and issued a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. SunTrust Banks, Inc. assumed coverage on shares of National Health Investors in a report on Tuesday, October 10th. They issued a hold rating and a $80.00 target price on the stock. Mizuho reiterated a hold rating and issued a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. Finally, Stifel Nicolaus reiterated a buy rating and issued a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. The company currently has an average rating of Hold and an average price target of $80.14.
Shares of National Health Investors (NHI) traded up $0.23 during trading hours on Friday, hitting $76.66. 223,200 shares of the stock were exchanged, compared to its average volume of 192,348. The firm has a market cap of $3,183.84, a price-to-earnings ratio of 14.71, a P/E/G ratio of 3.79 and a beta of 0.58. National Health Investors has a 12 month low of $67.33 and a 12 month high of $81.21. The company has a current ratio of 12.72, a quick ratio of 12.45 and a debt-to-equity ratio of 0.84.
National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). The company had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.74% and a net margin of 59.70%. The company’s revenue was up 14.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.22 earnings per share. equities analysts forecast that National Health Investors will post 5.25 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “National Health Investors, Inc. (NHI) Upgraded by Zacks Investment Research to Buy” was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.watchlistnews.com/national-health-investors-inc-nhi-upgraded-by-zacks-investment-research-to-buy/1698764.html.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be issued a dividend of $0.95 per share. The ex-dividend date is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.96%. National Health Investors’s dividend payout ratio is currently 95.00%.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 5.19% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in the business. Legal & General Group Plc increased its stake in National Health Investors by 13.9% in the 3rd quarter. Legal & General Group Plc now owns 116,146 shares of the real estate investment trust’s stock valued at $8,980,000 after buying an additional 14,142 shares during the period. American International Group Inc. increased its stake in National Health Investors by 8.1% in the 3rd quarter. American International Group Inc. now owns 26,648 shares of the real estate investment trust’s stock valued at $2,060,000 after buying an additional 1,993 shares during the period. Pacer Advisors Inc. increased its stake in National Health Investors by 11.7% in the 3rd quarter. Pacer Advisors Inc. now owns 7,402 shares of the real estate investment trust’s stock valued at $572,000 after buying an additional 775 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in National Health Investors in the 3rd quarter valued at approximately $249,000. Finally, Ameriprise Financial Inc. increased its stake in National Health Investors by 46.6% in the 3rd quarter. Ameriprise Financial Inc. now owns 78,030 shares of the real estate investment trust’s stock valued at $6,034,000 after buying an additional 24,790 shares during the period. Hedge funds and other institutional investors own 70.13% of the company’s stock.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.